GC69467
Mirzotamab
Mirzotamab is an IgG1κ antibody that targets CD276/B7-H3· Mirzotamab can form a complex with the BCL inhibitor Clezutoclax to create Mirzotamab clezutoclax, which is being studied for relapsed/refractory solid tumors in combination with paclitaxel· Mirzotamab clezutoclax (ABBV-155) is a targeted antibody-drug conjugate (ADC)
ChemicalCAS2229859-11-2
- CAS number
- 2229859-11-2
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC69467
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il